¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"mastoid cell"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
Leydig cell tumor
¶óÀ̵ðÈ÷¼¼Æ÷Á¾¾ç
light cell
¹àÀº¼¼Æ÷
lipoid cell
ÁöÁú¼¼Æ÷
luteal cell
Ȳ(»ö)ü¼¼Æ÷
lymphoid cell
¸²ÇÁ°è¼¼Æ÷, ¸²ÇÁ¸ð¾ç¼¼Æ÷
lymphokine-activated killer cell
¸²Æ÷Ä«ÀÎȰ¼º»ìÇØ¼¼Æ÷
lymphopoietic cell
¸²ÇÁ±¸Çü¼º¼¼Æ÷
lymphosarcoma cell leukemia
¸²ÇÁÀ°Á¾¼¼Æ÷¹éÇ÷º´
lacunar cell
°ø°£¼¼Æ÷
mitotic cell
À¯»çºÐ¿±â¼¼Æ÷
mitral cell
½Â¸ð¼¼Æ÷
mixed germ cell tumor
È¥ÇÕÁ¾ÀÚ¼¼Æ÷Á¾¾ç
monocyte-macrophage cell system
´ÜÇÙ±¸Å«Æ÷½Ä¼¼Æ÷°èÅë, ´ÜÇÙ±¸´ë½Ä¼¼Æ÷°èÅë
mononuclear cell
´ÜÇÙ¼¼Æ÷, ´ÜÇÙ±¸
mossy cell
À̳¢¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
nurse cell
(¢¡supporting cell) ¹öÆÀ¼¼Æ÷
oat cell carcinoma
±Í¸®¼¼Æ÷¾ÏÁ¾
osmiophilic cell
Ä£¿À½º¹Å¼¼Æ÷
oxyntic cell
(¢¡parietal cell) º®¼¼Æ÷
oxyphilic cell
È£»ê¼¼Æ÷
packed red blood cell
³óÃàÀûÇ÷±¸
parafollicular cell
¼ÒÆ÷°ç¼¼Æ÷
paralutein cell
ȲüÁÖÀ§¼¼Æ÷, ºÎȲü¼¼Æ÷
parietal cell
º®¼¼Æ÷
pathologic cell
º´Àû¼¼Æ÷
perivascular cell
Ç÷°üÁÖÀ§¼¼Æ÷
phagocytic cell
Æ÷½Ä¼¼Æ÷
pheochrome cell
ºÎ½Åģũ·Ò¼¼Æ÷
photoreceptor cell
(¢¡visual cell) ½Ã°¢¼¼Æ÷
physaliphorous cell
´ã°øÆ÷¼¼Æ÷
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
hodgkins disease,reed-sternberg cell in
¸®À̵å-½ºÅ׸¥º£¸£±× ¼¼Æ÷
horny cell
°¢Áú¼¼Æ÷
huma immunodeficiency virus,follicular dendritic cell infection by
¿©Æ÷»ó¼öÁö¼¼Æ÷°¨¿°
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type I
Á¦1Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T¼¼Æ÷¹éÇ÷º´¹ÙÀÌ·¯½º
human T cell leukemia virus type II
Á¦2Çü »ç¶÷ T ¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
human T-cell lymphotrophic virus
Àΰ£ T¼¼Æ÷ ¸²ÇÁ ¿µ¾ç¼º ¹ÙÀÌ·¯½º
human t-cell leukemia virus
ÀÎü T¼¼Æ÷ ¹éÇ÷º´ ¹ÙÀÌ·¯½º
hybrid cell
ÇÏÀ̺긮µå¼¼Æ÷
hybridoma, B cell
B¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
hybridoma, T cell
T¼¼Æ÷ ÇÏÀ̺긮µµ¸¶
hypercomplex cell
Ãʺ¹ÇÕ¼¼Æ÷(õ±ÜÜùêá¬øà)
hypersensitivity reactions,type ii(antibody-dependent cell-mediate cyt
IIÇü
hypersensitivity reactions,type iv(cell-mediated)
IVÇü
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
cell junction
¼¼Æ÷°æ°è, ¼¼Æ÷¿¬Á¢(¡ææïÈ).
cell killing
¼¼Æ÷»ìÇØ
cell labelling technique
¼¼Æ÷Ç¥Áö±â¹ý
cell lethality
¼¼Æ÷Ä¡»çÀ²
cell like colloidal drop
¼¼Æ÷¾çÄÝ·ÎÀ̵å¾×Àû.
cell line
¼¼Æ÷°è, ¼¼Æ÷ÁÖ
cell line
¼¼Æ÷°è(á¬øàͧ).
cell line
¼¼Æ÷°è(á¬øàͧ).
cell line, established
È®¸³¼¼Æ÷ÁÖ
cell loss
¼¼Æ÷¼Ò½Ç
cell loss factor
¼¼Æ÷¼Ò½Ç°è¼ö
cell lysis
¼¼Æ÷¿ëÇØ
cell mass
¼¼Æ÷µ¢¾î¸®, ¼¼Æ÷±«
cell mass
¿ø±â¼¼Æ÷±º(ê«Ðñá¬øàÏØ).
cell matrix
¼¼Æ÷±âÁú
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
17
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½